2024 / ELTE PPK Institute of Psychology
Psychedelic psychotherapies
Time: 2024 autumn semester (Sep 20, Oct 4, Oct 18, Nov 8, Nov 22, Dec 6), Friday 14.00-17.00
Place: ELTE "IZU", Bp. VI. Izabella utca 46.
Classroom: room #9 'Tornaterem' (ground floor)
Lecturer: Dr Levente Móró <drleve@iki.fi>
Course code: PPK-PSY:64
Credits: 4
Course Description
The course introduces students to the rising field of psychedelic
psychotherapies that are expected to have a major impact on mental
health care worldwide within a few years. It focuses on the background
information, requirements, techniques and protocols that psychologists
need to know when working in psychedelics-assisted therapies, or with
clients who wish to integrate their previous psychedelic experiences.
Course Topics
- altered states of consciousness; psychedelics
- transpersonal psychology; trauma processing and regression;
- psychedelic research, experiments and healing
- psychometric measuring; addictions and dependence; assisted
psychotherapies; ethics
- psychedelic and psycholytic therapies; therapist training; therapy
protocols
- MDMA, psilocybin, ketamine, LSD, ibogaine, ayahuasca
- psychedelic experience integration
Presentations:
- [01] Sep 20
[01.1] Course Introduction and Overview
Description.
Topics.
Requirements.
Practical issues.
Overview of presentations.
[01.2] Altered State Assisted Therapies
Altered states of consciousness (ASC): definitions and phenomena.
Spontaneous, pathological and induced states.
Physiological, pharmacological and psychological inductions.
Altering subsystems of consciousness.
Therapeutic applications of ASC.
[01.3] The Broader Context of Psychedelics
Hallucinations: definitions and phenomena.
Hallucinogens: dissociative, deliriant, psychedelic.
Other related substances.
Purposes of substance use.
The drug instrumentalisation hypothesis.
Psychonaut subculture.
Biohacking.
Móró (2024) Psychedelic Psychotherapies [01] @ ELTE.pdf
- [02] Oct 4
[02.1] Psychedelics: Substance Information
History, physiology, psychology and phenomenology of psychedelics and related substances: ayahuasca, cannabis, DMT, ibogaine, ketamine, LSD, MDMA, muscimol, psilocybin, salvinorin A, LSA, mescaline.
[02.2] Psychology of Psychedelic Experience
Psychoeducation.
Theories and models.
Set and setting.
Intention and integration.
Deconditioning agents.
Transpersonality and spirituality.
Entheogens.
Trauma processing and regression.
Stanislav Grof and the perinatal matrix.
Metaphysical considerations.
[02.3] Psychedelics: Research, Experiments, Healing (Will be lectured on Oct 18!)
The dawn, golden age, pause and renaissance of psychedelic research.
Early results.
Current research directions.
Psychometric measuring instruments.
Treatments of addictions and dependence.
Hospice use: end-life anxiety.
Móró (2024) Psychedelic Psychotherapies [02] @ ELTE.pdf
- [03] Oct 18
[03.1] Psychedelic Assisted Psychotherapies: Theory
Ethical principles.
Psychedelic and psycholytic therapies.
Lay and underground therapies.
Therapist training process.
Therapy protocols: MAPS, Johns Hopkins, Kenézy hospital.
[03.2/I] Psychedelic Assisted Psychotherapies: Practice I
MDMA.
[03.2/II] Psychedelic-Assisted Psychotherapies: Practice II
Psilocybin.
Ketamine.
[03.2/III] Psychedelic-Assisted Psychotherapies: Practice III
LSD.
Ibogaine.
Ayahuasca.
- [04] Nov 8
[04.1] Psychedelic Experience Integration
Client groups.
Conditions and environment of client-work.
Search for meaning, apprehension.
The lived body experience.
Psychedelic 'bypass' and ego inflation.
Non-pathologising language use.
Transference and counter-transference.
Data protection.
- [05] Nov 22
[05] INTERACTIVE!
Interactive practices and other surprises... :D
(no slideshow, no video)
- [06] Dec 6
[06] Brief summary of presentations 01-04
Back to main page